SPP1 and AGER as potential prognostic biomarkers for lung adenocarcinoma

Overdue treatment and prognostic evaluation lead to low survival rates in patients with lung adenocarcinoma (LUAD). To date, effective biomarkers for prognosis are still required. The aim of the present study was to screen differentially expressed genes (DEGs) as biomarkers for prognostic evaluation...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Weiguo, Fan, Junli, Chen, Qiang, Lei, Caipeng, Qiao, Bin, Liu, Qin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5962856/
https://www.ncbi.nlm.nih.gov/pubmed/29849788
http://dx.doi.org/10.3892/ol.2018.8235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5962856/
https://www.ncbi.nlm.nih.gov/pubmed/29849788
http://dx.doi.org/10.3892/ol.2018.8235

Ejemplares similares